Novartis: Klaus Moosmayer
Klaus Moosmayer will step into the recently created position of chief ethics, risk and complication officer at Novartis. The position has existed at the company since 2014, but recently expanded in April 2018 to include risk management. In this role, Moosmayer will also sit on the executive committee.
Moosmayer will join Novartis after having spent 18 years working at Siemens as its chief compliance officer, taking up his new position on December 1, 2018. Notably, Moosmayer is the chair of the anti-corruption taskforce at the Organization for Economic Co-operation and Development (OECD).
The appointment has been announced in the same year that Novartis came under scrutiny for employing President Trump’s lawyer, Michael Cohen, as a consultant to the company. It led to the company publically acknowledging that it had “made a mistake entering into the contract with Michael Cohen”.
Moosmayer said of his appointment: “It is a great honour for me to be given the opportunity to join Novartis. Society has high expectations of the pharmaceutical industry and rightfully so. I am pleased to see that there is already a strong focus on driving personal accountability for behaviours, and generating learnings that can be applied across the organisation within Novartis. I look forward to building on this strong foundation to create a truly world-class risk and compliance function.”